EGFR and cancer: The ERBB family includes four distinct types of transmembrane tyrosine kinase receptors (EGFR, HER-2, HER-3 and HER-4), which are responsible for the establishment of several intracellular signaling pathways associated with normal cellular function and cancer cell development [50,51].